Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
ReplyCorrespondence

Ms. A.M. Taylor, et al reply

ANN M. TAYLOR, JUSTIN O. TAYLOR, JASVINDER A. SINGH, PHILIP G. CONAGHAN, ERNEST H. CHOY, PETER S. TUGWELL, ULRIKE KAISER, VIBEKE STRAND, LEE S. SIMON and PHILIP J. MEASE
The Journal of Rheumatology April 2016, 43 (4) 826-827; DOI: https://doi.org/10.3899/jrheum.151456
ANN M. TAYLOR
Cardiff University, Cardiff, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: TaylorAM@cardiff.ac.uk
JUSTIN O. TAYLOR
Barry Chiropractic Clinic, Cardiff, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JASVINDER A. SINGH
Medicine Service, VA Medical Center, Department of Medicine at the School of Medicine, and Division of Epidemiology at the School of Public Health, University of Alabama at Birmingham, and Department of Orthopedic Surgery, Mayo Clinic College of Medicine, Birmingham, Alabama, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP G. CONAGHAN
Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds and UK National Institute for Health Research Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ERNEST H. CHOY
Cardiff University, Cardiff, UK;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PETER S. TUGWELL
Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ULRIKE KAISER
University Hospital Carl Gustav Carus, Dresden, Germany;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
VIBEKE STRAND
Division of Immunology/Rheumatology, Stanford University, Palo Alto, California, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LEE S. SIMON
SDG LLC, Cambridge, Massachusetts, USA;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
PHILIP J. MEASE
Swedish Medical Center and University of Washington, Seattle, Washington, USA.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • References
  • PDF
  • eLetters
PreviousNext
Loading

To the Editor:

We thank Drs. Ruan and Kaye for their comments1 on our paper2. The topic is important, so further debate over what chronic pain (CP) is helps to refine our thinking.

Voting was undertaken using a computerized, button-press system and the responses were therefore accurately recorded. Rather than being surprised at the 9% response rate that CP is a “disease,” we felt that the 31% who responded “none of the above” was more puzzling. On reflection, it may be that the cases presented around what CP actually is could have been stronger or that it was a relatively new concept to ask participants to change their existing opinion that CP is a symptom, to one that embraces pain as a disease, and hence participants were left wanting more information before they decided. As you have correctly suggested, the response may also reflect how “disease” was defined. A “blanket” definition of CP as a disease may also not be appropriate and the definition may depend on the CP condition. Indeed, in someone with new-onset rheumatoid arthritis, for instance, pain could be seen as a symptom of this condition and managing the condition may lead to the symptom of pain being reduced. However, in chronic low back pain, the individual may have large psychosocial issues mediating the pain experience, and the lack of a specific diagnosis and the chronic nature of the experience may render this as a disease. This supports your contentions that persistent pain is multifaceted and can be regarded as having different effects on individuals, and may be related to different rates of progression and the effect that the pain has on function, mood, lifestyle, etc. We agree that there is a spectrum in which persistent pain could range from being a symptom of a disease to a disease in itself depending on its effect and peripheral and central neuroplasticity.

The term “longterm condition (LTC)” was used because in the United Kingdom, the British Pain Society, the Chronic Pain Policy Coalition, Pain UK, and other CP organizations have worked hard to raise the profile of those living with or experiencing chronic and persistent pain. Having persistent pain mandated as an LTC meant that services for persistent pain could become more equitable to those for other LTC and would no longer be dismissed as a symptom. In 2008, the Welsh government accepted that persistent pain was an LTC, and this was followed by other countries within the United Kingdom. The consideration in the United Kingdom that pain is an LTC should mean that those living with persistent pain are managed using multidisciplinary models of care and that most management centers around community and primary care, and as with other LTC, still have access to specialist multidisciplinary teams.

We agree that it is important to define persistent pain in a scientific yet practical way, but do not agree that biological measures have had almost no effect on psychiatric practice. Neuroscience has made a number of contributions using functional magnetic resonance imaging techniques and brain markers for diagnosis in a number of psychiatric conditions3,4,5,6. However, as you state, there exists a large body of evidence now illustrating peripheral and central neuroplastic reorganization underlying the disease of CP, which is influenced by biopsychosocial factors.

There are advantages for using the “multifaceted disease” model of persistent pain, as you rightly address. Seeing persistent pain as an LTC and/or a disease is a relatively new concept and conversations such as these help to encourage clinicians to think holistically about the individual living with persistent pain, rather than regarding pain as a symptom that needs to be medically managed with, for example, drug therapy. We applaud the final sentence in your letter: we should do anything within our power to help those living with persistent pain. We add to this power, the importance of shared decision making and evidence-based practice.

REFERENCES

  1. 1.↵
    1. Ruan X,
    2. Kaye AD
    . Defining chronic pain. J Rheumatol 2016;43:826.
    OpenUrlFREE Full Text
  2. 2.↵
    1. Taylor AM,
    2. Phillips K,
    3. Taylor JO,
    4. Singh JA,
    5. Conaghan PG,
    6. Choy EH,
    7. et al.
    Is chronic pain a disease in its own right? Discussions from a pre-OMERACT 2014 workshop on chronic pain. J Rheumatol 2015;42:1947–53.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Bleich-Cohen M,
    2. Jamshy S,
    3. Sharon H,
    4. Weizman R,
    5. Intrator N,
    6. Poyurovsky M,
    7. et al.
    Machine learning fMRI classifier delineates subgroups of schizophrenia patients. Schizophr Res 2014;160:196–200.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Agarwal N,
    2. Port JD,
    3. Bazzocchi M,
    4. Renshaw PF
    . Update on the use of MR for assessment and diagnosis of psychiatric diseases. Radiology 2010;255:23–41.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Koutsouleris N,
    2. Meisenzahl EM,
    3. Davatzikos C,
    4. Bottlender R,
    5. Frodl T,
    6. Scheuerecker J,
    7. et al.
    Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 2009;66:700–12.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Fu CH,
    2. Mourao-Miranda J,
    3. Costafreda SG,
    4. Khanna A,
    5. Marquand AF,
    6. Williams SC
    Pattern classification of sad facial processing: toward the development of neurobiological markers in depression. Biol Psychiatry 2008;63:656–62.
    OpenUrlCrossRefPubMed
View Abstract
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 43, Issue 4
1 Apr 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Ms. A.M. Taylor, et al reply
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Ms. A.M. Taylor, et al reply
ANN M. TAYLOR, JUSTIN O. TAYLOR, JASVINDER A. SINGH, PHILIP G. CONAGHAN, ERNEST H. CHOY, PETER S. TUGWELL, ULRIKE KAISER, VIBEKE STRAND, LEE S. SIMON, PHILIP J. MEASE
The Journal of Rheumatology Apr 2016, 43 (4) 826-827; DOI: 10.3899/jrheum.151456

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Ms. A.M. Taylor, et al reply
ANN M. TAYLOR, JUSTIN O. TAYLOR, JASVINDER A. SINGH, PHILIP G. CONAGHAN, ERNEST H. CHOY, PETER S. TUGWELL, ULRIKE KAISER, VIBEKE STRAND, LEE S. SIMON, PHILIP J. MEASE
The Journal of Rheumatology Apr 2016, 43 (4) 826-827; DOI: 10.3899/jrheum.151456
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics
  • References
  • PDF
  • eLetters

Related Articles

Cited By...

More in this TOC Section

  • Drs. Schneeberger and Citera reply
  • Dr. Kitajima et al reply
  • Dr. Putman et al reply
Show more Correspondence

Similar Articles

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire